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Abstract Periplasmic molecular chaperone LolA and the inner
membrane ATP binding cassette transporter LolCDE are essen-
tial for ATP-dependent release of outer membrane-directed lipo-
proteins from the inner membrane of Escherichia coli. A Lo-
lA(F47E) mutant carrying a Phe to Glu mutation at position 47
was defective in the release of lipoproteins from spheroplasts
and proteoliposomes reconstituted with LolCDE. When incuba-
ted with proteoliposomes containing LolCDE, LolA remained
in the supernatant whereas LolA(F47E) bound to proteolipo-
somes. This tight association of LolA(F47E) with LolCDE
caused a dominant negative phenotype in vivo, suggesting that
the LolA^LolCDE interaction is critical for lipoprotein
release. ( 2002 Federation of European Biochemical Soci-
eties. Published by Elsevier Science B.V. All rights reserved.
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1. Introduction
Escherichia coli possesses more than 90 lipoproteins, most
of which are anchored to the outer membrane through
N-terminal lipids [1]. Lipid modi¢cation and processing to
mature lipoproteins occur on the periplasmic surface of the
inner (cytoplasmic) membrane [2]. An ATP binding cassette
(ABC) transporter, LolCDE, in the inner membrane releases
outer membrane-speci¢c lipoproteins that possess amino acid
residues other than Asp at position 2, leading to the forma-
tion of a LolA^lipoprotein complex [3,4]. When this complex
interacts with outer membrane receptor LolB, the associated
lipoprotein is transferred from LolA to LolB, followed by
anchoring to the outer membrane [5,6]. Asp at position 2 of
lipoproteins functions as a LolCDE avoidance signal, thereby
causing the retention of lipoproteins in the inner membrane
[1].
Five Lol proteins are essential for E. coli growth [7^9] and
widely conserved in Gram-negative bacteria [3,10]. In addition
to lipoprotein binding and interaction with LolB, LolA is
expected to interact with LolCDE at the step of lipoprotein
release. However, this has not been demonstrated. In contrast,
MalFKG2, an ABC transporter mediating maltose uptake,
was recently shown to bind a periplasmic maltose binding
protein, MalE, at the transition step of the uptake reaction
[11].
We recently constructed LolA derivatives carrying single
mutations at conserved residues. LolA(R43L) was found to
be defective in the transfer of associated lipoproteins to LolB,
causing the accumulation of the LolA^lipoprotein complexes
in the periplasm [10]. Among the isolated LolA mutants only
LolA(F47E) exhibited a dominant negative phenotype, i.e. the
expression of LolA(F47E) inhibited growth even in the pres-
ence of wild-type LolA. We report here that LolA(F47E) is
inactive in the release reaction and tightly associates with
LolCDE.
2. Materials and methods
2.1. Materials
LolA and its F47E derivative having a His-tag at its C-terminus
were puri¢ed to homogeneity with Talon metal a⁄nity resin (Clon-
tech). LolCDE was puri¢ed as reported [1]. Restriction enzymes were
purchased from Takara Shuzo Co. Isopropyl L-D-thiogalactopyrano-
side (IPTG) was from Sigma. Antibodies against LolA [4], Pal [7],
Lpp [12], and OmpA [13] were prepared as described. Tran35S label
was obtained from ICN.
2.2. Bacteria and media
E. coli TT016 carried the chromosomal lolA gene under the control
of the lactose promoter^operator [10]. Expression of the chromosomal
lolA gene was induced with 1 mM IPTG. MC4100 [14] was used to
prepare spheroplasts as described [4]. E. coli strains were grown at
37‡C on L-broth or M63 minimal medium supplemented with 0.2%
maltose.
2.3. Mutagenesis of Phe at position 47 of LolA
As reported for the construction of LolA(R43L) [10], Phe at posi-
tion 47 of LolA was mutagenized by means of polymerase chain
reaction using a Quick change site-directed mutagenesis kit (Strata-
gene) with pAM201 encoding LolA-His [10] as a template and a pair
of oligonucleotides, 5P-GGGTGAAACGTCCAAACTTANNNAA-
CTGGCATATGACACAACC-3P and 5P-GGTTGTGTCATATGCC-
AGTTNNNTAAGTTTGGACGTTTCACCC-3P, as primers, in
which each N represents the mixture of four nucleotides introduced
for mutagenesis. The plasmid DNAs were ampli¢ed in the XL1-Blue
strain lacking functional endonuclease R, and then transformed into
TT016 (lacPO-lolA). Chloramphenicol-resistant transformants were
selected on L-broth plates supplemented with 1 mM IPTG, and
then their growth in the absence of IPTG was examined on plates
containing arabinose. The plasmids harbored by transformants that
did not grow on these plates were expected to carry non-functional
lolA and therefore were sequenced to determine the mutations. To
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assure the mutations, DNA sequences were determined on both
strands. Where speci¢ed, growth of TT016 cells harboring the speci-
¢ed plasmids was examined in the presence of both 30 WM IPTG and
0.2% arabinose.
2.4. Release of Lpp from spheroplasts
The LolA-dependent release of lipoproteins from spheroplasts was
examined as described [4]. A suspension (300 Wl) containing 5U108
spheroplasts was kept on ice for 3 min in the presence and absence of
LolA. M63 medium (750 Wl) containing 0.25 M sucrose and 10 WCi of
Tran35S label (1000 Ci/mmol as [35S]Met) was then added for 2 min
labeling at 30‡C. The labeling was chased for 2 min by the addition of
non-radioactive Met and Cys (each at 12 mM). The release of lipo-
proteins was terminated by chilling of the reaction mixture in ice
water, and analyzed after fractionation into spheroplasts and medium
by centrifugation at 16 000Ug for 2 min.
2.5. In vitro membrane incorporation of Pal
LolB-dependent incorporation of Pal into outer membranes was
examined using 35S-labeled Pal released from spheroplasts as de-
scribed [5,6]. The membrane incorporation of Pal was terminated by
chilling of the reaction mixture in ice water, and analyzed after frac-
tionation into a supernatant and pellet by centrifugation at
100 000Ug for 30 min.
2.6. Immunoprecipitation, SDS^polyacrylamide gel electrophoresis
(PAGE), and Western blot analyses
35S-labeled lipoproteins were immunoprecipitated with antibodies
against the respective lipoproteins and then analyzed by SDS^
PAGE, followed by £uorography with Enlightning (NEN Life Science
Products) as described [4]. The amounts of lipoproteins were deter-
mined with an ATTO Densitograph. Western blot analyses were per-
formed as described [6]. The blots were densitometrically quantitated
at least twice within 5% deviation.
2.7. Reconstitution of proteoliposomes
Proteoliposomes were reconstituted with LolCDE (4 Wg), L10P
(1 Wg), and 0.8 mg E. coli phospholipids in the presence of ATP as
reported [1,3]. The release of L10P from the proteoliposomes was
examined in the presence of 2 mM ATP and 10 Wg/ml LolA or Lo-
lA(F47E) at 30‡C for 20 min. The reaction mixture was fractionated
into proteoliposomes and a supernatant by centrifugation at
100 000Ug for 30 min, followed by SDS^PAGE and immunoblotting.
3. Results
3.1. LolA(F47E) inhibits the growth of E. coli
TT016 (lacPO-lolA) cells required the induction of LolA
with IPTG for growth (Fig. 1). Expression of LolA from
both chromosome and plasmid by the addition of IPTG
and arabinose had no e¡ect on growth (compare the open
and closed squares). As reported previously for LolA(R43L)
[10], mutagenized lolA was expressed from a plasmid by the
addition of arabinose, and defective LolA mutants that did
not support the growth of TT016 in the absence of IPTG were
isolated. Among these mutants, one carried on pAMF47E was
found to inhibit the growth of TT016 not only in the absence
(open circles) but also in the presence (closed circles) of IPTG,
Fig. 1. LolA(F47E) is a dominant negative mutant. TT016 (Plac-
lolA-his) cells harboring pAM201 (PBAD-lolA-his, diamonds and
squares) or pAF47E (PBAD-lolA(F47E)-his, circles) were grown at
37‡C in the presence and absence of IPTG and/or arabinose, as
speci¢ed. The growth of cells was monitored by following the tur-
bidity of cultures at 660 nm. The data obtained from a single ex-
periment are shown. Open diamonds, 3arabinose/3IPTG; open
squares, +arabinose/3IPTG; closed squares, +arabinose/+IPTG;
open circles, +arabinose/3IPTG; closed circles, +arabinose/+IPTG.
Fig. 2. LolA(F47E) is defective in lipoprotein-releasing activity.
Spheroplasts were prepared from MC4100 cells harboring pTAN21
[6], which carried Ptac-pal, induced for 5 min with 1 mM IPTG.
A: Pulse-labeling and the chase were performed as described under
Section 2 in the presence of 10 Wg/ml LolA or LolA(F47E).
B: Spheroplasts were pulse-labeled for 1 min in the presence of 3 Wg/
ml LolA or LolA(F47E), and then chased for the indicated times.
The data obtained from a single experiment are shown.
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indicating a dominant negative phenotype. This mutant
(F47E) was found to carry a Phe (TTC) to Glu (GAA) muta-
tion at position 47. Other mutants, which have Lys (AAG),
Asp (GAT) or Pro (CCA) in place of Phe at position 47, were
also isolated as defective mutants but did not exhibit a dom-
inant negative phenotype.
3.2. LolA(F47E) is defective in the release reaction
The release of outer membrane lipoproteins Lpp and Pal
from spheroplasts was examined in the presence of 10 Wg/ml
LolA or LolA(F47E) (Fig. 2A). Outer membrane protein
OmpA, which is not modi¢ed by lipids, was secreted into
the medium irrespective of the presence or absence of LolA,
whereas that of Lpp absolutely required LolA as reported
[4,6]. When LolA(F47E) was used in place of LolA, only a
marginal amount of Lpp was released. In contrast to Lpp, a
small amount of Pal was released in a LolA-independent man-
ner and the addition of LolA caused the complete release of
Pal as reported [6]. LolA(F47E) was found to be as active as
wild-type LolA as to the release of Pal. It was shown previ-
ously that the release of Pal was more e⁄cient than that of
Lpp [6]. Since these results suggested that LolA(F47E) was a
leaky mutant, the release of Pal was examined in the presence
of a subsaturating amount (3 Wg/ml) of LolA or LolA(F47E)
(Fig. 2B). Under these conditions, the release of Pal induced
by LolA(F47E) was less e⁄cient than that by LolA, indicating
that LolA(F47E) is generally defective in the lipoprotein re-
leasing activity.
3.3. LolA(F47E) can transfer associated lipoproteins to LolB
Pal was released from spheroplasts on the addition of 10
Wg/ml LolA or LolA(F47E). As a control, wild-type LolA [4]
having no His-tag was also used for the release assay. The
spheroplast supernatant containing released Pal was then ap-
plied on a metal-chelating column (Fig. 3). Neither LolA nor
Pal bound to the resin when the release reaction had been
performed with LolA having no His-tag (lane 3). In contrast,
when the release reaction had been carried out with LolA-His,
not only LolA but also Pal bound to the resin (lane 6), in-
dicating the formation of a LolA^Pal complex. Pal released in
the presence of LolA(F47E) also bound to the resin, indicat-
ing that this mutant is able to form a complex with Pal (lane
9). However, the amounts of Pal released into the medium
(compare lanes 4 and 7) and bound to the resin (lanes 6
and 9) were smaller with LolA(F47E) than with wild-type
LolA. Moreover, a small amount of Pal did not bind to the
resin when the release reaction had been performed with Lo-
lA(F47E). Taken together, these results indicate that Lo-
lA(F47E) is a leaky mutant defective in the release of lipopro-
teins. Since the release of Lpp more strongly depends on the
LolA function than that of Pal [6], the defect of this mutant
seemed to be more clearly observed in the release of Lpp.
It was previously reported that LolA(R43L) was defective
in the transfer of associated lipoproteins to LolB [10]. To
Fig. 3. LolA(F47E) forms a complex with released Pal. The release
of 35S-labeled Pal from spheroplasts was performed for 5 min in the
presence of 10 Wg/ml LolA, LolA-His or LolA(F47E)-His as in Fig.
2. The spheroplast supernatants (lanes 1, 4 and 7) were applied on
a metal-chelating column. Unbound fractions (lanes 2, 5 and 8)
were obtained by washing the column with 10 mM Tris^HCl (pH
7.5). Bound fractions (lanes 3, 6 and 9) were eluted with 50 mM
Tris^HCl (pH 7.5) containing 250 mM imidazole. Equivalent
amounts of the fractions were analyzed by SDS^PAGE and immu-
noblotting for LolA or £uorography for Pal.
Fig. 4. LolA(F47E) is active as to the transfer of associated Pal to
LolB. Spheroplast supernatants containing 35S-labeled Pal as a com-
plex with LolA-His (open circles) or LolA(F47E)-His (closed circles)
were prepared as in Fig. 3 and then incubated with 0.2 mg/ml outer
membrane at 30‡C for the speci¢ed times. After the reaction, Pal re-
covered in the outer membrane fraction was detected by £uorogra-
phy (A) and quantitated (B). Where speci¢ed, LolB-depleted outer
membranes prepared as reported [6] were used as a control
(squares).
Fig. 5. LolA(F47E) tightly associates with LolCDE. Proteolipo-
somes were reconstituted with LolCDE, L10P, and E. coli phospho-
lipids as described under Section 2. The release of L10P was in-
duced by the addition of LolA or LolA(F47E). After fractionation
into proteoliposomes and a supernatant, L10P and LolA or Lo-
lA(F47E) were analyzed by SDS^PAGE and immunoblotting with
anti-Lpp or anti-LolA antibodies. One-¢fth of the pellet material
and one-¢fth of the supernatant were applied to the gel for the
analysis of L10P and LolA, respectively. Proteoliposomes reconsti-
tuted without LolCDE were used as a control.
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examine the lipoprotein transfer activity of the LolA(F47E)
mutant, a spheroplast supernatant containing the Pal^LolA or
Pal^LolA(F47E) complex was incubated with outer mem-
branes (Fig. 4). The ability to incorporate Pal into LolB-con-
taining outer membranes was essentially the same for LolA
and LolA(F47E). When LolB-depleted outer membranes were
used, the incorporation of Pal was negligible.
3.4. Tight association of LolA(F47E) with LolCDE
To clarify the properties of LolA(F47E) in more detail,
proteoliposomes were reconstituted with LolCDE, L10P,
and E. coli phospholipids. L10P, a derivative of Lpp, is suit-
able for in vitro analysis of the release reaction [15]. L10P
release was then examined in the presence of LolA or Lo-
lA(F47E) (Fig. 5). LolA(F47E) did not induce the release of
L10P from proteoliposomes, whereas LolA induced the re-
lease of L10P in a LolCDE-dependent manner. Immunoblot-
ting with anti-LolA antibodies revealed that LolA(F47E) was
recovered in the proteoliposome fraction after the release re-
action. The recovery of LolA(F47E) in this fraction was de-
pendent on LolCDE. In contrast, LolA was always recovered
in the supernatant. These results, taken together, suggest that
LolA(F47E) tightly associates with LolCDE, thereby inhibit-
ing the LolA-dependent release of lipoprotein in vivo (Fig. 1).
4. Discussion
When maltose uptake is inhibited by vanadate, MalE
tightly binds to MalFGK2, representing the transition state
of the maltose transporter [16]. In contrast, inhibition of lipo-
protein release by vanadate did not cause the tight association
of LolA and LolCDE (unpublished observation). The ATPase
activity of LolCDE was stimulated by lipoproteins but not
a¡ected by LolA [1]. Moreover, the LolCDE-dependent re-
lease of Pal occurred in the absence of LolA, albeit at a
reduced rate [6]. Taken together, these observations appeared
to suggest that the release of lipoproteins by LolCDE, and the
formation of a complex between the released lipoprotein and
LolA were separate events. However, the dominant negative
phenotype of LolA(F47E) strongly suggests that LolA and
LolCDE interact with each other when lipoproteins are re-
leased as a complex with LolA. The tight association between
LolA(F47E) and LolCDE most likely inhibits this interaction,
thereby causing growth inhibition even in the presence of
wild-type LolA. However, it is not completely clear at present
why LolA(F47E) was partially active as to the release of Pal,
since our preliminary results suggest that this tight association
is independent of lipoproteins.
The details of the molecular events occurring at the lipo-
protein release step are largely unknown. It would be of great
interest to determine how ATP energy is utilized to release
lipoproteins anchored to the inner membrane and then trans-
ferred to form the LolA^lipoprotein complex. LolA(F47E) is
expected to be very useful for determining the details of the
lipoprotein release reaction.
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